Private equity deal news and insights from the London newsroom

Archimed’s Denis Ribon: Add-ons planned for FIM Medical; MiddleGround completes Stemmer take-private

Morning all, Craig McGlashan here with the Europe Wire from the London newsroom.

This morning we speak to Archimed’s Denis Ribon about his private equity firm’s acquisition of FIM Medical and its M&A plans for the provider of vision, hearing and respiratory care products.

Next, MiddleGround Capital has wrapped up its take-private ofa machine and artificial vision technology provider.

We then look at DC Advisory’s ‘European Private Equity Mid-Market Monitor: Q3 2024 and Outlook’ report, released this morning, which is cautiously optimistic on dealmaking for next year.

Finally, the outcome of the US election is beginning to look clear as I write. I’d love to get readers’ thoughts on what impact the result will have on dealmaking in Europe and globally. Send them to me at [email protected]

Cross-border push

Archimed plans to turn Lyon, France-based FIM Medical into an international company by making add-on acquisitions in Europe, chairman and managing partner Denis Ribon told PE Hub’s Sophie Rose.

Find out more about the plans, Archimed’s activity in the neuro, sensory and occupational health sectors, and Ribon’s outlook for healthcare investing in the premium version of the Wire.

Vision play

MiddleGround Capital has completed its voluntary public takeover offer of Stemmer Imaging, a provider of machine and artificial vision technology.

Read more in the premium version of the Wire.

‘Mindset shift’

There are “reasons to be positive” about mid-market dealmaking in Europe next year, according to investment bank DC Advisory’s ‘European Private Equity Mid-Market Monitor: Q3 2024 and Outlook’ report, released this morning.

Find out why in the premium version of the Wire.

OK, that’s all from me today. Rafael Canton will write to you with the US Wire later today and I’ll be back on Europe duty tomorrow.

Cheers,

Craig

Read the full Wire commentary on PE Hub ...

Today's must reads

Also of note (may require subscriptions)

Brookfield Oaktree loses Greater China wealth head: Joy Wang built up Brookfield Oaktree's Hong Kong team, designing a strategy that helped raise over $1.4bn in two years from clients across Greater China, per her LinkedIn profile. (Private Equity International)

Off-duty: Daraja’s Raudline Etienne on Ella Fitzgerald, Haitian bouillon and the quest for diversity. Etienne tells Buyouts about her spiritual home in Brooklyn, her dream job as an interior designer, and why use of the word 'alpha' in private markets sometimes gives her pause.

New York City’s LPs face ban on private fossil fuel-related infrastructure: The proposal would place major challenges on the three pension funds, which have been regular investors in funds managed by Brookfield, KKR, Stonepeak and BlackRock. (New Private Markets)

Inside co-investment’s relentless rise: The subpar fundraising environment of the past two years has played a role in spurring interest in co-investments, but it’s not the only driving force behind the rising trend. (Private Funds CFO)

New US president may have little choice but to squeeze ag’s labor pool: Agriculture’s place as a beneficiary and magnet for immigrant labor will face greater scrutiny, regardless of who wins, after another election in which immigration has played a central role. (Agri Investor)

“We think there is room for acquisitions internationally, and we’re actively working on bringing some add-on acquisitions to FIM Medical.”

— Denis Ribon, chairman and managing partner, Archimed

Today's letter was prepared by Craig McGlashan

Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article.

London | New York | Hong Kong | Tokyo | Sydney

PEI Group Ltd is registered in England no.6135779

Registered office: 5th Floor, 100 Wood Street, EC2V 7AN

To update your PE Hub email preferences, or to unsubscribe, click here.